BU-NOT-SET CONTACT US All20252024202320222021 September 16 2024 Recipharm's investment enhances efficiency and speed for customers and patients September 09 2024 ReciBioPharm and Hongene Biotech Corporation establish a gene editing development partnership September 04 2024 Introducing ReciPredict: Revolutionising Drug Product Development and Manufacturing September 03 2024 Recipharm completes divestment of seven sites June 13 2024 MARBIO receives new grant funding April 02 2024 Recipharm strengthens its competitiveness by focusing on leading, core CDMO segments April 02 2024 Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm March 26 2024 Recipharm attains major sustainability milestones March 13 2024 ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors January 23 2024 Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology Pagination First page Previous page Page 1 Current page 2 Page 3 Page 4 … Next page Last page
